These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619). Yun JC; Ohman KP; Gill JR; Keiser H Can J Physiol Pharmacol; 1991 May; 69(5):599-604. PubMed ID: 1650650 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor. Puri RN; Colman RW J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172 [TBL] [Abstract][Full Text] [Related]
7. N-ethylmaleimide inhibits platelet aggregation and potentiates hydrogen peroxide formation induced by thrombin. Leoncini G Biochem Mol Biol Int; 1994 Aug; 34(1):119-26. PubMed ID: 7849614 [TBL] [Abstract][Full Text] [Related]
8. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets. Dorsam RT; Kim S; Jin J; Kunapuli SP J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512 [TBL] [Abstract][Full Text] [Related]
9. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of platelet aggregation from the Cyanophyceae Oscillatoria rosea (NIES-208). Rho MC; Matsunaga K; Yasuda K; Ohizumi Y Planta Med; 1996 Oct; 62(5):473-4. PubMed ID: 8923815 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability. Lanza F; Stierlé A; Gachet C; Cazenave JP Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093 [TBL] [Abstract][Full Text] [Related]
12. Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton. Torti M; Ramaschi G; Sinigaglia F; Lapetina EG; Balduini C Proc Natl Acad Sci U S A; 1994 May; 91(10):4239-43. PubMed ID: 8183895 [TBL] [Abstract][Full Text] [Related]
13. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334 [TBL] [Abstract][Full Text] [Related]
14. Receptor occupancy regulates Ca2+ entry and intracellular Ca2+ redistribution in activated human platelets. Brüne B; von Appen F; Ullrich V Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):993-9. PubMed ID: 7818507 [TBL] [Abstract][Full Text] [Related]
15. Galpha12 and galpha13 are phosphorylated during platelet activation. Offermanns S; Hu YH; Simon MI J Biol Chem; 1996 Oct; 271(42):26044-8. PubMed ID: 8824244 [TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2 and vascular smooth muscle cell proliferation. Sachinidis A; Flesch M; Ko Y; Schrör K; Böhm M; Düsing R; Vetter H Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017 [TBL] [Abstract][Full Text] [Related]
17. Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study. Barradas MA; Jagroop A; O'Donoghue S; Jeremy JY; Mikhailidis DP Thromb Res; 1993 Aug; 71(3):227-36. PubMed ID: 8267765 [TBL] [Abstract][Full Text] [Related]
18. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]